Antiarrhythmic drugs: electrophysiological actions.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D001949:Bretylium Compounds / Q000494:pharmacology; D002395:Catecholamines / Q000494:pharmacology; D004594:Electrophysiology; D005934:Glucagon / Q000494:pharmacology; D006321:Heart / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D008012:Lidocaine / Q000494:pharmacology; D008839:Microelectrodes; D010672:Phenytoin / Q000494:pharmacology; D011342:Procainamide / Q000494:pharmacology; D011802:Quinidine / Q000494:pharmacology; D011817:Rabbits; D013565:Sympatholytics / Q000494:pharmacology*
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D001949:Bretylium Compounds; D002395:Catecholamines; D013565:Sympatholytics; D010672:Phenytoin; D005934:Glucagon; D008012:Lidocaine; D011802:Quinidine; D011342:Procainamide